XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
Preferred Stock [Member]
Series A Preferred Stock [Member]
Preferred Stock [Member]
Series B Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Comprehensive Income [Member]
Total
Noncontrolling Interest [Member]
AOCI Including Portion Attributable to Noncontrolling Interest [Member]
Balance - December 31, 2023 at Dec. 31, 2022 $ 10 $ 21 $ 161,595 $ 31,136,120 $ (24,504,395) $ (33,557) $ 6,759,794 $ (924,377) $ 5,835,417
Shares, Issued at Dec. 31, 2022 10,000 21,000 161,595,511            
Series B Preferred stock issued as dividend $ 10 816,470 (816,480)
[custom:StockIssuedDuringPeriodSharesSeriesBPreferredIssuedAsDividend] 10,080            
Common stock issued for compensation $ 240 42,650 42,890 42,890
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture 240,000            
Common stock issued for warrant exercises $ 10,295 1,389,705 1,400,000 1,400,000
Stock Issued During Period, Shares, Conversion of Convertible Securities 10,294,119            
Resolution of derivative liabilities upon exercise of warrant 975,939 975,939 975,939
[custom:ResolutionOfDerivativeLiabilitiesShares]            
Dividend to non-controlling interest (5,050) (5,050)
[custom:DividendToNonControllingInterestShares]            
Foreign currency translation adjustments 8,217 8,217 7,895 16,112
Net income (loss) (763,258) (763,258) 543,822 (219,436)
[custom:CommonStockIssuedForSettlementOfDebtShares] 3,007,173            
Common stock issued in conjunction with convertible notes             1,400,000    
Stock Issued During Period, Shares, Conversion of Units     10,294,119            
Balance - December 31, 2024 at Dec. 31, 2023 $ 10 $ 31 $ 172,130 34,360,884 (26,084,133) (25,340) 8,423,582 (377,710) 8,045,872
Shares, Issued at Dec. 31, 2023 10,000 31,080 172,129,630            
Series B Preferred stock issued as dividend $ 10 627,700 (627,710)
[custom:StockIssuedDuringPeriodSharesSeriesBPreferredIssuedAsDividend] 8,959            
Common stock issued for compensation $ 600 140,425 141,025 141,025
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture 600,000            
Common stock issued for warrant exercises $ 10,000 1,090,000 1,100,000 1,100,000
Stock Issued During Period, Shares, Conversion of Convertible Securities 10,000,000            
Resolution of derivative liabilities upon exercise of warrant 1,493,046 1,493,046 1,493,046
[custom:ResolutionOfDerivativeLiabilitiesShares]            
Net income (loss) (5,991,567) (5,991,567) 811,531 (5,180,036)
Common stock issued for settlement of debt 3,007 480,663 483,670 483,670
Common stock issued for conversion of debt $ 6,106 665,560 671,666 671,666
Stock Issued During Period, Shares, Other   6,106,061            
Common stock issued in conjunction with convertible notes $ 3,535 594,242 597,777 597,777
Stock Issued During Period, Shares, Conversion of Units 3,535,354            
Common stock issued for the extension of debt $ 646 115,718 116,364 116,364
[custom:StockIssuedDuringPeriodSharesExtensionDebt] 646,467            
Common stock issued for conversion of series B preferred stock $ (5) $ 4,502 (4,497)
[custom:StockIssuedDuringPeriodSharesConversionOfSeriesBPreferred] (4,502) 4,502,000            
Common stock issued for cash $ 2,450 97,550 100,000 100,000
[custom:StockIssuedDuringPeriodSharesCash] 2,450,000            
Common stock payable 82,194 82,194 82,194
[custom:CommonStockPayableShares]            
Acquisition of subsidiary 4,248,685 4,248,685
[custom:CommonStockIssuedAcquisitionShares]            
Balance - December 31, 2024 at Dec. 31, 2024 $ 10 $ 36 $ 202,976 $ 39,743,485 $ (32,703,410) $ (25,340) $ 7,217,757 $ 4,682,506 $ 11,900,263
Shares, Issued at Dec. 31, 2024 10,000 35,537 202,976,685